MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines Psychedelics Investing
Amgen Announces Five-Year Data That Reinforce The Safety And Efficacy Profile Of Aimovig® In Adult Patients With Episodic Migraine Biotech Investing
Nutritional High Announces an Adjustment to the Terms for Meeting of the Senior Unsecured Convertible Debentures Cannabis Investing News
Bristol Myers Squibb Announces Update on CheckMate -915 Evaluating Opdivo Plus Yervoy Versus Opdivo in Resected High-Risk Melanoma Patients Biotech Investing
U.S. Food and Drug Administration Approves Opdivo® + Yervoy® as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma Biotech Investing
Algernon Announces 75% Enrollment in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
AbbVie to Present New Data From 15 Abstracts at the 2020 Virtual Migraine Trust International Symposium Biotech Investing
Merck Announces Retirement of Dr. Roger M. Perlmutter; Dr. Dean Y. Li Appointed as President, Merck Research Laboratories Pharmaceutical Investing
UNCF, Bristol Myers Squibb Announce Second Cohort of the Ernest E. Just Postgraduate Fellowship and Extension of Partnership Through 2026 Biotech Investing
 Bristol Myers Squibb to Host Virtual Investor Event to Discuss Results from Phase 3 True North Trial Evaluating Zeposia® in Ulcerative Colitis at UEG Week 2020 Biotech Investing
Perimeter Medical Imaging AI Announces Further Update Regarding Second Quarter Financial Statements Medical Device Investing
